Dali Pharmaceuticalco.,Ltd (603963.SS)
- Previous Close
4.9700 - Open
4.8800 - Bid --
- Ask 4.7200 x --
- Day's Range
4.7200 - 4.9200 - 52 Week Range
4.7200 - 15.9700 - Volume
11,451,866 - Avg. Volume
13,203,087 - Market Cap (intraday)
1.037B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 23, 2021
- 1y Target Est
--
Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection. The company's products include xingnaojing, shenmai, and astragalus injections, as well as citicoline injections. It also has patents, including invention patents and utility models. The company was founded in 1996 and is headquartered in Dali, China.
www.daliyaoye.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 603963.SS
Performance Overview: 603963.SS
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603963.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603963.SS
Valuation Measures
Market Cap
1.09B
Enterprise Value
900.17M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
16.83
Price/Book (mrq)
2.91
Enterprise Value/Revenue
13.70
Enterprise Value/EBITDA
-112.85
Financial Highlights
Profitability and Income Statement
Profit Margin
-34.78%
Return on Assets (ttm)
-3.17%
Return on Equity (ttm)
-5.90%
Revenue (ttm)
65.7M
Net Income Avi to Common (ttm)
-22.85M
Diluted EPS (ttm)
-0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
215.41M
Total Debt/Equity (mrq)
6.30%
Levered Free Cash Flow (ttm)
-20.38M
Research Analysis: 603963.SS
Company Insights: 603963.SS
603963.SS does not have Company Insights